GLP-1 support, clinical care, and new programs for sleep and women's health
These programs build on the cardiometabolic program. Each one is marked as live, delivered by provider partners, or announced and rolling out.
Live, inside the Dario Health app
GLP-1 support
For members on or considering a GLP-1 medication: education, an onboarding guide, medication tracking, and coaching on nutrition and side effects.
Through provider partners, where available
Where your contract includes it, licensed providers can evaluate members and, when clinically appropriate, prescribe FDA-approved GLP-1 medications. This is available for commercial populations, subject to state and contract.
Through provider partners, or your own network
Clinical care
When a member needs a clinician, Dario can route them to licensed provider partners or to your own network, depending on your configuration. Behavioral therapy is available by referral to an outside network.
| Commercial | Available, subject to state and contract |
|---|---|
| Medicare Advantage | Not yet confirmed; assessed per plan and contract |
| Medicaid | Not currently available; referral to the plan's network |
Announced by Dario; expected rollout fall 2026, with availability confirmed per client
Dario Sleep
A sleep apnea screening questionnaire within the cardiometabolic program, a one-night home sleep test read by licensed providers, and therapy chosen by the provider, delivered through partners.
Announced by Dario; expected rollout fall 2026, with availability confirmed per client
Dario Women
Support for perimenopause and menopause, with coaching from Dario and clinical evaluation, including for hormone therapy where appropriate, through provider partners.
Availability
Ask about timing
Availability dates for Dario Sleep and Dario Women are confirmed with each client.
Talk through what your population needs
We will confirm which programs and clinical services are available for you.